載入...
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
Chimeric antigen receptor T (CAR-T) cell therapy has produced impressive results in clinical trials for B-cell malignancies. However, safety concerns related to the inability to control CAR-T cells once infused into the patient remain a significant challenge. Here we report the engineering of recomb...
Na minha lista:
發表在: | Proc Natl Acad Sci U S A |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
National Academy of Sciences
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4743815/ https://ncbi.nlm.nih.gov/pubmed/26759369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1524155113 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|